CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 40
- Registration Number
- NCT04680715
- Locations
- 🇫🇷
Pôle Santé République, Clermont-Ferrand, France
🇫🇷Centre Antoine Lacassagne, Nice, France
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 88
- Registration Number
- NCT04616846
- Locations
- 🇫🇷
Clinique Saint-Jean, Cagnes-sur-Mer, Alpes-Maritimes, France
🇫🇷Clinique Saint-Georges, Nice, Alpes-Maritimes, France
🇫🇷CHU Nice, Nice, Alpes-Maritimes, France
COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 214
- Registration Number
- NCT04492410
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 155
- Registration Number
- NCT04198727
- Locations
- 🇲🇨
Hôpital Princesse Grâce, Monaco, Monaco
🇫🇷Clinique Saint Jean, Cagnes-sur-Mer, France
🇫🇷Centre Antoine Lacassagne, Nice, France
Organoids From Metastases of Prostate Cancer
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 1
- Registration Number
- NCT03952793
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
THrombo-Embolic Event in Onco-hematology
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 700
- Registration Number
- NCT03826043
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-07-12
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 100
- Registration Number
- NCT03584334
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 103
- Registration Number
- NCT03548428
- Locations
- 🇫🇷
Centre Georges François LECLERC, Dijon, France
🇫🇷Centre Oscar LAMBRET, Lille, France
🇫🇷Centre François BACLESSE, Caen, France
Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 30
- Registration Number
- NCT03467360
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 44
- Registration Number
- NCT03371550
© Copyright 2024. All Rights Reserved by MedPath